MARKET

LIVN

LIVN

Livanova Plc
NASDAQ
63.90
+0.61
+0.96%
After Hours: 62.99 -0.91 -1.42% 16:36 12/04 EST
OPEN
63.18
PREV CLOSE
63.29
HIGH
64.18
LOW
62.56
VOLUME
496.02K
TURNOVER
--
52 WEEK HIGH
64.31
52 WEEK LOW
32.48
MARKET CAP
3.49B
P/E (TTM)
-15.9308
1D
5D
1M
3M
1Y
5Y
1D
LivaNova (LIVN): Assessing Valuation After CMS Boosts Reimbursement for VNS Therapy Procedures
Simply Wall St · 3h ago
LivaNova To Present Eight Posters At AES Highlighting VNS Therapy's Seizure Reduction And Improved Outcomes In Drug-Resistant Epilepsy
Benzinga · 1d ago
LivaNova Highlights CORE-VNS Study Showing VNS Therapy Reduces Seizure Frequency and Healthcare Costs in Drug-Resistant Epilepsy
Reuters · 1d ago
LivaNova Names Lucile Blaise Global Head of Commercialization for Obstructive Sleep Apnea
Reuters · 2d ago
LIVANOVA APPOINTS LUCILE BLAISE AS GLOBAL HEAD OF COMMERCIALIZATION, OBSTRUCTIVE SLEEP APNEA
Reuters · 2d ago
Weekly Report: what happened at LIVN last week (1124-1128)?
Weekly Report · 3d ago
LivaNova (LIVN) Is Up 5.5% After Medicare Boosts VNS Therapy Reimbursement—Has the Bull Case Changed?
Simply Wall St · 3d ago
LivaNova CFO to Present Business Update at Piper Sandler Healthcare Conference
Reuters · 11/25 14:00
More
About LIVN
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.

Webull offers LivaNova PLC stock information, including NASDAQ: LIVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIVN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LIVN stock methods without spending real money on the virtual paper trading platform.